Navigation Links
AngioGenex Reviews 2008 Achievements and Sets Goals for 2009
Date:11/25/2008

NEW YORK,Nov. 25 /PRNewswire-FirstCall/ -- AngioGenex, Inc. (OTC Bulletin Board: AGGX) is a New York-based biotechnology company that leads in targeting Id genes and proteins for the discovery and development of anti-angiogenic drugs to treat cancer. Today the Company announced achievement of its 2008 objectives and its key business goals for 2009.

AngioGenex accomplished a number of important milestones that it set for itself in 2008. In the Research and Development area, the Company completed key pilot studies on novel anti-angiogenic drugs and filed US and foreign patent applications for these agents. A major goal of 2008 was to complete in vivo studies of its lead small molecule drug candidate (AGX51) that would establish the ability of the agent to reduce angiogenesis and to block the growth and metastasis of tumors. According to Dr. Garland, "the data from those studies clearly met this goal and AGX51 has the potential of being the first orally active anti-angiogenic drug that acts by a mechanism not associated with VEGF, the target of Avastin(R), Genentech's blockbuster anti-cancer drug." Moreover, the results demonstrated that mice tolerate AGX51 without any apparent side effects.

In the corporate area, Dr. Richard Salvador, the former global head of Preclinical Development at Hoffmann La Roche, Inc. became Chairman of the Board of Directors and Dr. Garland, who has led the company's drug discovery and development effort, became the CEO.

AngioGenex took important steps to satisfy its near term corporate finance needs and to meet its future capital formation goals. The Company raised a modest amount of equity capital from new and existing shareholders to fund the AGX51 pilot studies, and it retained Griffin Securities LLC, an investment banking firm specializing in early stage biotechnology companies. Working with Griffin, the Company has identified a number of potential corporate pa
'/>"/>

SOURCE AngioGenex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. William Garland Joins AngioGenexs New Board of Directors
2. AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs
3. CBDM.T, The Market and Business Intelligence Company Reviews The Enzyme Market
4. CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market
5. Pharma Opinions Site Reviews the Breakthrough Drugs of Pharmaceutical Companies
6. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
7. Rudd Report Highlights AMDL, Inc.s Latest Business Achievements; Supports 2008 Financial Guidance
8. Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results
9. Millennium Over-Delivers on 2007 Goals and Financial Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... , May 16, 2013  HealthSparq, a ... of the nation,s largest regional health plans, will ... Health Insurance Plans (AHIP) Institute 2013 conference on ... survey results showing how health insurance companies across ... the consumer and marketplace demands for increased healthcare ...
(Date:5/16/2013)... As the weather warms, women everywhere are waiting for ... most make a statement with fashion, many change their makeup ... weather mixes makeup and sweat to produce, and increase acne ... during warmer months, Adult Acne treatment , Probiotic Action ... ways to deter breakouts. , Recently, an article from ...
(Date:5/16/2013)... NEW YORK , May 16, ... a new market research report is ... MediPoint: Diagnostic Cardiac Biomarkers for ... and Market Forecasts ... Cardiac Biomarkers for Acute Coronary Syndromes ...
(Date:5/16/2013)... Dr. Stephen Y. Chou, Founder of Nanonex Corporation, will ... at IEEE Nano 2013 in Beijing, China, on August ... is becoming one of the most critical nanofabrication technologies ... resolution, large area, and low cost unmatchable by other ... in a broad range of industries, from ICs, nano/micro ...
Breaking Biology Technology:HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 5MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 6MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 7MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 8Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013 2
... SEATTLE, April 12, 2011 EMC Corporation (NYSE: ... solutions, today announced that Sanford-Burnham Medical Research Institute , ... Institutes of Health (NIH) grant funding and among the top ... EMC Isilon® scale-out NAS as the primary ...
... 2011 Reportlinker.com announces that a new market research ... Biomarker Partnering Terms and Agreements ... The Biomarker Partnering Terms and Agreements report provides comprehensive ... and agreements entered into by the worlds leading healthcare ...
... holds intriguing possibilities for the future of industrial ... green energy technologies as artificial photosynthesis, researchers with ... National Laboratory (Berkeley Lab) have created bilayered nanocrystals ... to feature multiple catalytic sites on nanocrystal interfaces. ...
Cached Biology Technology:Sanford-Burnham Turns Big Data Into Scientific Breakthroughs With EMC Isilon 2Sanford-Burnham Turns Big Data Into Scientific Breakthroughs With EMC Isilon 3Reportlinker Adds Biomarker Partnering Terms and Agreements 2Reportlinker Adds Biomarker Partnering Terms and Agreements 3Reportlinker Adds Biomarker Partnering Terms and Agreements 4Reportlinker Adds Biomarker Partnering Terms and Agreements 5Reportlinker Adds Biomarker Partnering Terms and Agreements 6Reportlinker Adds Biomarker Partnering Terms and Agreements 7Reportlinker Adds Biomarker Partnering Terms and Agreements 8Berkeley Lab researchers report tandem catalysis in nanocrystal interfaces 2Berkeley Lab researchers report tandem catalysis in nanocrystal interfaces 3
(Date:5/16/2013)... have used ancient shorelines to predict the stability of today,s ... high shoreline from three million years ago, for example ... thought to be evidence of a high sea level due ... led many scientists to think that if the world,s largest ... just the same in our modern, progressively warming world. ...
(Date:5/16/2013)... choose to wear the color red when they compete? ... Science , a journal of the Association for Psychological ... their testosterone levels. , The new study, conducted by ... and colleagues, demonstrated that males who chose red as ... levels than other males who chose blue. , "The ...
(Date:5/16/2013)... the entirety of an individual,s DNA is examined to ... cause health problems is a massively useful technology for ... ethical problems if used incorrectly, say new recommendations from ... line today (16 May 2013) in the European ... whole genome and on exome* sequencing and analysis are ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2High-testosterone competitors more likely to choose red 2European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2
... of Health has awarded $4 million to a group ... Natural Sciences, to aid in the discovery of new ... in the Philippines. , Research will be concentrated in ... estimated 10,000 marine mollusk speciesabout a fifth of all ...
... to introduce plant-eating predators to fight a superweed spreading ... bullet, says a world expert on Japanese knotweed at ... the Department of Biology has been researching the invasive ... students Michelle Hollingsworth and Catherine Pashley. Research ...
... controlled trial called the "Evaluate the Clinical use of ... trial, Angela Cheung and colleagues at the University of ... supplement did not protect against age-related bone mineral density ... PLoS Medicine , the findings also suggest that vitamin ...
Cached Biology News:Academy participates in project to discover drugs, biofuels in tropical seas 2'Plant-eating predator to fight superweed is not magic bullet' 2
... Smart Solutions has now entered the next ... by partnering up with Cellomics, Inc. The ... integration of Beckman Coulter‘s automated solutions systems ... biological information at the sub-cellular level. The ...
Immunogen GST fusion protein corresponding to full-length rat JNK3/ SAPK1b. Quality Assurance Routinely evaluated by immunoblot. Stability 2 years at -20°C from date of shipment GenBank A...
... research and biologic production demands on cell ... confirming viable cell populations. Therefore, both cell ... be determined accurately and precisely. The new ... and cost effective means to perform the ...
... modification that plays an important role ... inflammation, cell-to-cell adhesion, and cell signaling. ... based Glycoprotein Isolation Kits, Concanavalin A ... that allow isolation of glycoproteins from ...
Biology Products: